RxDoctor Payments Data

Courtney Wright

Adult Health · Boaz, ALNPI 1770040941

Payments from drug & device makers

$334in general payments, 2019–2025

Across 21 payments — averaging $15.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kowa Pharmaceuticals America, Inc.$78
  • Amgen$49
  • GSK$42
  • AbbVie$33
  • Novo Nordisk$32
  • Merck$29
  • plus $71 from 5 others

What the payments were for

  • Food & beverage$334100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$334 in reported general payments places this provider in the 45th percentile of 308 adult health providers in Alabama.

See all adult health providers in Alabama

Medicare billing

Part B allowed, 2024
$7,301
Medicare patients
69
Services billed
193

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban41$32,853
JardianceEmpagliflozin43$28,845
JanuviaSitagliptin Phosphate26$19,705
FarxigaDapagliflozin Propanediol25$19,095
XareltoRivaroxaban19$14,808
Tresiba Flextouch U-200Insulin Degludec11$8,802
Esomeprazole Magnesium35$4,317
PremarinEstrogens, Conjugated11$3,714
Levothyroxine Sodium230$3,460
LantusInsulin Glargine,hum.Rec.Anlog17$3,409
Celecoxib59$3,239
Atorvastatin Calcium182$2,876
Fluticasone-SalmeterolFluticasone Propion/Salmeterol15$2,847
Raloxifene Hcl31$2,782
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$2,687

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$29$19,70526 claims
AstraZenecaFarxiga$14$19,09525 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 308 adult health providers in Alabama.

Other adult health in Boaz

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →